本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

38.58
+1.143.04%
盘前37.21-1.3700-3.55%04:52 EDT
成交量:165.81万
成交额:6,283.31万
市值:71.73亿
市盈率:-10.78
高:38.68
开:37.41
低:36.92
收:37.44
数据加载中...
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/23

重要事件披露

Form 8-K - Current report
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities